Does Medicare Cover Zepbound for Weight Loss? The Pen Matters
6 min read
Does Medicare cover Zepbound for weight loss? Yes, but only through a temporary program, and only for one version of the drug. Since July 1, 2026, Medicare's weight loss drugs page says the program covers the Zepbound KwikPen for eligible people with Part D drug coverage. The cost is $50 a month. Single-dose Zepbound pens and vials are not covered, and that detail trips people up at the pharmacy counter.
How the Medicare GLP-1 Bridge works
The program is called the Medicare GLP-1 Bridge. CMS describes the Bridge as a $50 copay arrangement that sits outside the regular Part D benefit. It runs nationwide, including all states and U.S. territories. It works with a standalone drug plan, a Medicare Advantage plan with drug coverage, a Special Needs Plan, an employer or union group waiver plan, or the LI NET program. Some plan types do not qualify when they are your only coverage: private fee-for-service, cost contract and PACE plans. Not sure what you have? Call 1-800-MEDICARE.
Who qualifies for Zepbound under the Bridge
Medicare will cover Zepbound for weight loss only when you are 18 or older and meet one of three BMI tiers at the start of therapy. A higher BMI needs no extra condition, while the lower tiers need a qualifying diagnosis. The table below shows the criteria Medicare lists.
| BMI at start | Also required |
|---|---|
| 35 or higher | No additional condition |
| 30 or higher | Heart failure with preserved ejection fraction (HFpEF), uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher |
| 27 or higher | Prediabetes, a previous heart attack or stroke, or blocked arteries in the legs or arms with symptoms |
| Source | Medicare.gov |
Your doctor calculates BMI from your height and weight, so ask for the number if you don't know it. Your provider must also certify that you are using the drug as part of a lifestyle program focused on diet and exercise. You cannot already get a GLP-1 drug through your Part D plan. Because eligibility turns on diagnoses, costs and suitability vary, and a licensed prescriber should confirm what applies to you.
Which Zepbound pen Medicare pays for
Medicare lists three covered products: Foundayo tablets, Wegovy as an injection or tablet, and the Zepbound KwikPen. Lilly's Medicare page adds that the Bridge may cover the KwikPen for single-patient use, at no more than $50 a month. The single-dose pen and the vials fall outside the program. So the product named on your prescription matters as much as your diagnosis.
Ask your prescriber and pharmacist which Zepbound product the prescription names, since the choice of product is a clinical decision. Compounded tirzepatide is not FDA-approved and is not on the covered list, so the Bridge does not apply to it. Lilly also warns against sharing a KwikPen with anyone, even when the needle changes, because of infection risk.
What the $50 copay does not do
When Medicare covers Zepbound for weight loss through the Bridge, the $50 payment sits outside your regular drug plan, and that has four consequences.
- It does not count toward your Part D deductible or yearly out-of-pocket limit.
- It will not appear on your Part D Explanation of Benefits or on any Medicare Summary Notice.
- Extra Help cannot lower it.
- The Medicare Prescription Payment Plan cannot spread it across months.
In practice, treat the $50 as a separate, flat monthly cost. Medicare's fact sheet says it applies no matter your income level, which is why Extra Help has no effect on it. A fill also does not bring you closer to your plan's yearly limit. Cash purchases with discount cards work the same way, because Medicare says they do not count toward your deductible or out-of-pocket maximum.
Does Medicare cover Zepbound for weight loss if you are excluded?
Three groups fall outside the Bridge. People already receiving a GLP-1 through their Part D plan must keep getting it there. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are also excluded, although Medicare notes their plan might already cover a GLP-1. For these groups, your plan's own formulary and prior authorization rules decide, so contact the plan directly.
KFF's explainer on the temporary program describes the Bridge as a short-term route for GLP-1s approved for weight reduction, namely Wegovy and Zepbound. That framing explains why the route sits apart from standard coverage. A Zepbound prescription for sleep apnea, for example, could run through plan rules instead of the Bridge.
From prescription to pharmacy counter
The path follows a set order, and your doctor handles most of the paperwork.
- Your doctor sends a prescription for a covered GLP-1 drug to your pharmacy.
- The pharmacy may ask for your Medicare ID number or the last four digits of your Social Security Number.
- After the pharmacy gets confirmation that you are eligible, your doctor submits a prior authorization form.
- Medicare mails you a letter confirming coverage.
- You pick up the drug and pay $50 for a one-month supply, either 28 or 30 days depending on the drug.
- Refills need no new approval if you stay on the same drug, even when the dose changes.
Medicare says the approval holds, including for refills and dose changes, through December 31, 2027, unless you change GLP-1s. Because the Bridge is a temporary program, ask your plan or 1-800-MEDICARE what happens after that date. If you suspect fraud, call the same number.
Other ways to lower the cost if you don't qualify
When Medicare does not cover Zepbound for weight loss in your case, its own page lists several fallbacks. Check whether the drug's maker offers help paying for it, and find out if your state helps with drug costs. Mail-order pharmacies are sometimes cheaper, so compare. If you have no drug coverage, you can sign up for a plan at certain times of the year.
TrumpRx.gov lists special offers and cash prices for comparison, but you cannot buy drugs there directly. Medicare adds that discount cards are not creditable coverage, so cash spending outside your plan will not count toward your deductible. Read any manufacturer program's terms for Medicare enrollees before you rely on it, since eligibility rules differ by program.
Action Steps
- Confirm your drug coverage: Check that you have Part D through a standalone plan or a Medicare health plan with drug coverage. Call 1-800-MEDICARE if you are unsure.
- Check your BMI tier: Ask your doctor for your BMI and whether you have a qualifying condition for your tier.
- Rule out exclusions: If you have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, or already get a GLP-1 through your plan, contact your Part D plan.
- Confirm the product: Ask your prescriber which Zepbound product the prescription names and whether it is the covered KwikPen.
- Have your Medicare ID ready: Keep your Medicare card handy for the pharmacy, or know the last four digits of your Social Security Number.
- Budget the $50 separately: Treat the copay as its own monthly cost and note that the approval runs through December 31, 2027 unless you change GLP-1s.
Frequently Asked Questions
Does Medicare cover Zepbound vials?
Not under the Medicare GLP-1 Bridge. Medicare says the single-dose Zepbound pen and Zepbound vials are not covered, and only the KwikPen is.
Does the $50 copay count toward my Part D deductible?
No. Medicare says the $50 payment does not count toward your drug plan deductible or yearly out-of-pocket limit.
Can I use the Bridge if I have sleep apnea?
People with moderate-to-severe sleep apnea are not eligible for the Bridge. Medicare says to contact your drug plan, which might already cover a GLP-1 for you.
How long does Medicare's approval last?
Prior authorization is valid, including for refills and dose changes, through December 31, 2027, unless you change GLP-1s.
Can I spread the $50 over several months?
No. These drugs are not eligible for the Medicare Prescription Payment Plan, and Extra Help cannot lower the copay.